ABSTRACT
Elevated intracranial pressure (ICP) can cause optic nerve head edema (ONHE), commonly referred to as papilledema. Elevated ICP is usually confirmed by manometric measurement of CSF opening pressure (OP) during lumbar puncture (LP). Previously, an OP greater than 20 cm H 2 0 in children was considered elevated. 1, 2 However, some authors have reported that "normal" adults and children can have an OP as high as 28 cm H 2 O. [3] [4] [5] [6] In a prospective study of CSF OP in children, we reported that an abnormal CSF OP in children was greater than 28 cm H 2 O. 6 Since elevated ICP can cause ONHE, we would expect that most patients with ONHE not due to infectious, inflammatory, or ischemic conditions would have an OP greater than 28 cm H 2 O.
This study describes the range of OP for children with ONHE not due to infectious, inflammatory, or ischemic conditions and compared them with age-matched controls without ONHE.
METHODS Patients. Subjects comprising this cohort were selected from a large prospective study performed at The Children's Hospital of Philadelphia (Philadelphia, PA), an urban tertiary care children's hospital. Inclusion and exclusion criteria have previously been described in detail. 6 Briefly, children 1-18 years of age undergoing LP in the lateral recumbent position as part of their clinical care were prospectively identified to participate. Those with documented ONHE on fundus examination with subsequent resolution were eligible for inclusion as case subjects in the present study. Patients with ONHE secondary to inflammatory (e.g., sarcoid), ischemic (e.g., vasculitis), or infections (i.e., Lyme disease) were excluded. Any subject (case or control) with abnormal CSF constituents (i.e., CSF white blood cells greater than 8 per mm 3 or protein Ͼ60 mg/dL), indwelling ventricular shunts, past or current diagnosis of a brain tumor, and abnormal MRI findings (i.e., demyelinating disease, optic neuritis, hydrocephalus, Chiari malformation, transependymal CSF flow) were excluded. Patients with a diagnosis of Guillain-Barré syndrome or a radiographic diagnosis of sinovenous thrombosis were included as cases since the etiology of their ONHE was presumably directly related to elevated ICP. Subjects without ONHE were chosen from the previously published study as control subjects. 6 Control subjects were matched 1:1 to case subjects based on age (within 6 months), category of sedation depth during LP (no sedation, mild sedation, moderate/severe sedation), and agebased body mass index category (underweight Ͻ5%, normal weight 5%-84%, overweight 85-95%, and obese Ͼ95%).
7
Standard protocol approvals, registrations, and patient consents. Consent from the parent and verbal assent from the child (when applicable) was obtained prior to enrollment. Institutional review board approval was obtained prior to study initiation. Study definitions and protocol. Diagnosis of ONHE was made by a pediatric neuro-ophthalmologist or ophthalmologist (n ϭ 35) or pediatric neurologist (n ϭ 6). The patient's history, presence or absence of ONHE on fundus examination, resolution of ONHE, laboratory results, and discharge diagnosis were obtained through review of medical records with a minimum follow-up of 6 months after the date of the LP. The medical history of patients found to have ONHE was specifically reviewed to identify any known risk factors for developing idiopathic intracranial hypertension (IIH). Risk factors for IIH, defined according to 2 expert reviews, 8, 9 included anemia, obesity, receipt of tetracycline-based medications, withdrawal from chronic corticosteroid therapy within the past 2 months, growth hormone injections, topical or systemic retinoids, and vitamin A supplements.
Statistical analysis. Continuous variables were described using means, median, and range. Categorical variables were described using frequencies and percentages. Paired t test was used to compare the OP distribution between case and control subjects. Data were analyzed using commercially available software (STATA, version 11; StataCorp, College Station, TX). A 2-tailed p value Ͻ0.05 was considered statistically significant.
RESULTS ONHE was identified in 60 (12.7%) of the 472 enrolled subjects. Twenty-seven subjects with ONHE were excluded for the following conditions: Lyme disease (n ϭ 8), demyelinating/white matter disease (n ϭ 4), drusen/anomalous optic nerves (n ϭ 3), vasculitis/inflammatory (n ϭ 5), sarcoid (n ϭ 1), polyarteritis nodosum (n ϭ 1), acute lymphoblastic leukemia (n ϭ 1), suspected viral meningitis (n ϭ 1), pituitary hypophysitis (n ϭ 1), and optic nerve structural anomalies (n ϭ 2).
Forty-one OP measurements were obtained from the 33 patients with ONHE who did not have any exclusionary criteria. The table lists the demographic and clinical characteristics of case subjects with ONHE and control subjects without ONHE. The difference in mean OP between case and controls subjects was 22.5 cm H 2 O (p Ͻ 0.01). Forty of 41 (97.6%) LPs performed on ONHE case subjects had OP measurements Ͼ28 cm H 2 O as compared to 2 of 41 (4.8%) control subjects with OP measures Ͼ28 cm ( 2 ϭ 70.48, p Ͻ 0.01; figure) . ONHE was attributed to withdrawal of chronic steroids in 2 subjects and ingestion of minocycline in 5 subjects. Three case subjects were taking acetazolamide at the time of their LP and had OP measurements of 34, 44, and 53 cm H 2 O. Elimination of these 3 subjects from the analysis did not alter the large difference in mean OP between case and control subjects ( p Ͻ 0.01). Large differences in mean OP between groups remained ( p Ͻ 0.01) when stratified by age (i.e., prepubertal Ͻ8 years old, peripubertal 9 -12 years old, and postpuberty 13-18 years old). 
DISCUSSION
This study demonstrates that an overwhelming majority of children found to have ONHE not due to infectious, inflammatory, or ischemic conditions and which later resolved have an OP greater than 28 cm H 2 O. All but one case subject with ONHE had an OP 10 cm H 2 O above the previously defined upper limit of normal (i.e., 20 cm H 2 0).
1,2 However, nearly 40% (16 of 41) of control subjects without ONHE had an OP greater than 20 cm H 2 O. Although possible, it is doubtful this many control subjects had a clinically significant elevation in their ICP. These findings provide further support to our previously published findings that suggests an abnormal OP in children is typically above 28 cm H 2 O and likely indicative of elevated ICP. 6 Our observations are relevant for several reasons. Foremost, the diagnostic criteria for IIH have required an OP greater than 25 cm H 2 O. 9 This study provides prospective data that support these criteria, but also suggest that the OP criteria in children may need to be increased to greater than 28 cm H 2 O. Moving the criteria to greater than 28 cm H 2 O may provide diagnostic clarity to children found to have an OP below this level who present with headache but without papilledema or to asymptomatic children discovered to have an OP that would previously have been considered abnormal. A recent study reported children with IIH had an OP above 28 cm H 2 O, while all but one subject diagnosed with pseudopapilledema had an OP below 30 cm H 2 O. 10 Increasing the OP criteria is further supported by the findings from our large prospective study that concluded that an abnormal OP in children was greater than 28 cm H 2 O. 6 The only subject in our study diagnosed with intracranial hypertension who had an OP below 28 cm H 2 O had undergone renal transplantation and developed ONHE following withdrawal of long-term oral corticosteroids. Her LP demonstrating an OP of 22 cm H 2 O was performed after restarting her oral corticosteroids. She still had papilledema, but most symptoms of IIH had improved following resumption of corticosteroid therapy.
This study may be limited by the fact that control subjects without ONHE may not have experienced elevated ICP long enough to produce ONHE. Additionally, control subjects did not undergo follow-up LPs to determine if their OP continued to rise. Clinician's knowledge of the presence or absence of ONHE at the time of LP may have influenced their final determination of the OP. The validity of our study results is strengthened by the prospective design that avoids biases inherent in retrospective case series. Additionally, most case subjects received an evaluation by the same experienced pediatric neuroophthalmologist, minimizing the consequences of interobserver variability in diagnosis of ONHE. The inclusion criteria that required that case subjects demonstrate subsequent resolution of ONHE decreased the chances of including subjects with elevated optic nerves not related to increased intracranial pressure (i.e., optic nerve drusen or anomalous optic nerves).
A measurement or indication of elevated ICP is required to further define ONHE as papilledema. Throughout the current study, we chose to use the term ONHE rather than papilledema since it would be inappropriate to have our primary outcome measure (i.e., OP) define our subject classification (i.e., case).
Our prospective study examining the relationship between OP and ONHE found that most children with ONHE not related to infectious, inflammatory, or ischemic causes typically have an OP greater than 28 cm H 2 O. This study provides further support to our previously published findings that suggests an abnormal OP in children is typically above 28 cm H 2 O and indicative of elevated ICP.
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